Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
University of Arizona
Julie E Bauman; Nabil F Saba; Denise Roe; Jessica R Bauman; John Kaczmar; Aarti Bhatia; Jameel Muzaffar; Ricklie Julian; Steven Wang; Shethal Bearelly; Audrey Baker; Conor Steuer; Anshu Giri; Barbara Burtness; Sara Centuori; Carlos Caulin; Robert Klein; Kathylynn Saboda; Stefanie Obara; Christine H Chung
Department of Epidemiology and Biostatistics, UA Mel and Enid Zuckerman College of Public Health, Tucson, AZ. ; Biostatistics and Bioinformatics Shared Resource, UA Comprehensive Cancer Center, Tucson, AZ.